National ANTIBIOTIC RESISTANCE Portal
Private Collaborative Access
Home • French research forces • Teams • AUBRY Alexandra

A Decrease font size. A Reset font size. A Increase font size.

FRENCH RESEARCH FORCES

AUBRY Alexandra

Scientific file / structure
Translate with

Scientist:

 AUBRY Alexandra

Address:

 /

http://www.cimi-paris.upmc.fr/fr/les-equipes/emergence-et-propagation-des-multi-resistances-aux-antibiotiques.html

Area of intervention:

 Antibiotics and alternative therapies, Strain and sample biobanks, Bioinformatics - modeling - structure, Biomarkers, Sampling - detection and diagnosis, Clinical trials, Genetics and genomics, Technological innovations and "omics", Microbial defense mechanisms, Microorganisms and host interactions/response, Experimental models, Networks, One Health Sectors, Social sciences / Public health / Public policies / Socio-economics, Bacterial strains
Antibiotic resistance acquisition, Therapeutic alternatives, Antibiotics and antibiotic therapy, Omic approaches, Bacteriophage and phagotherapy, Systems biology, Crystallography and structural biology, Emergence of antimicrobial resistance, Enterobacteriaceae, Epidemiology - surveillance - monitoring, Virulence factors, Genetics and genomics, In vitro, Respiratory infections, Host-pathogen interactions, Klebsiella, Resistance mechanisms, Hospital and intensive care setting, Animal models, Mycobacteria, Pre-clinical studies, Human health

Unity;

 INSERM U1135

Team name:

 Centre national de référence des Mycobactéries et de la résistance des mycobactéries aux antituberculeux

Responsible:
(Unit director / head of structure)​

 /

Type of structure:

 Academic

Affiliation:

 Sorbonne Université / Inserm U11135 / Cimi-Paris / AP-HP Sorbonne-Université (site Pitié-Salpêtrière)

Region:

 IDF

City:

 Paris

Description:​

Notre équipe cherche à comprendre les mécanismes d’émergence et de diffusion de la multirésistance bactérienne aux antibiotiques, dans deux modèles : les mycobactéries, notamment Mycobacterium tuberculosis (Mtb) agent de la tuberculose, et les entérobactéries, notamment Klebsiella pneumoniae (KP).
L’équipe travaille en étroite collaboration avec le Centre National de Référence des mycobactéries.